Research graph
References from A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME). Local targets link to admitted publications; unresolved targets remain external evidence.
Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
10.1111/j.0013-9580.2005.66104.x · 2005 · External reference
Unresolved reference
2010 · External reference
Seizures and Epilepsy: An Overview for Neuroscientists
10.1101/cshperspect.a022426 · 2015 · External reference
Commission for Classification and Terminology
2017 · External reference
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial
10.1016/s0140-6736(07)60461-9 · 2007 · External reference
Idiopathic generalized epilepsy: Lack of significant microdysgenesis
10.1212/wnl.55.8.1101 · 2000 · External reference
Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: An extended study
10.1111/epi.13061 · 2015 · External reference
Juvenile myoclonic epilepsy: Clinical characteristics, standard and quantitative electroencephalography analyses
10.4103/1817-1745.117835 · 2013 · External reference
Juvenile myoclonic epilepsy: Psychiatric comorbidity and impact on outcome
10.1016/j.yebeh.2013.03.026 · 2013 · External reference
Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients
10.1002/epi4.12321 · 2019 · External reference
10.5772/57431
10.5772/57431 · External reference
Treatment of Juvenile Myoclonic Epilepsy
10.1111/j.1755-5949.2008.00046.x · 2008 · External reference
Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors
10.1111/ene.13811 · 2019 · External reference
Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
10.3389/fneur.2019.00946 · 2019 · External reference
Juvenile myoclonic epilepsy: Challenges on its 60th anniversary
10.1016/j.seizure.2016.09.005 · 2017 · External reference
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
10.1371/journal.pmed.1000097 · 2009 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · 2021 · External reference
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
10.1186/2046-4053-4-1 · 2015 · External reference
Rayyan—a web and mobile app for systematic reviews
10.1186/s13643-016-0384-4 · 2016 · External reference
Drug-Resistant Epilepsy
10.1056/nejmra1004418 · 2011 · External reference
Limited Ability to Adjust N2 Amplitude During Dual Task Walking in People With Drug-Resistant Juvenile Myoclonic Epilepsy
10.3389/fneur.2022.793212 · 2022 · External reference
Seizure and social outcomes in patients with juvenile myoclonic epilepsy (JME)
10.1016/j.seizure.2022.03.002 · 2022 · External reference
Juvenile Myoclonic Epilepsy: Seizure and Social Outcomes in Taiwan
2023 · External reference
Clinical factors related to treatment resistance in juvenile myoclonic epilepsy
10.5692/clinicalneurol.48.727 · 2008 · External reference
Seizure control with valproic acid, lamotrigine or levetiracetam in the management of drug-resistant juvenile myoclonic epilepsy. Systematic review and meta-analysis
2022 · External reference
Sex-specific disease modifiers in juvenile myoclonic epilepsy
10.1038/s41598-022-06324-2 · 2022 · External reference
Clinical and EEG Features of Therapy-Resistant Patients with Juvenile Myoclonic Epilepsy
2004 · External reference
Seizure outcome in 175 patients with juvenile myoclonic epilepsy—A long-term observational study
10.1016/j.eplepsyres.2014.09.008 · 2014 · External reference
Role of the Risk Factors and Family History on the Prognosis of Patients with Juvenile Myoclonic Epilepsy
2005 · External reference
Prolonged epileptiform EEG runs are associated with persistent seizures in juvenile myoclonic epilepsy
10.1016/j.eplepsyres.2017.05.003 · 2017 · External reference
Prognosis of juvenile myoclonic epilepsy is related to endophenotypes
10.1016/j.seizure.2010.10.004 · 2011 · External reference
Prognosis of juvenile myoclonic epilepsy 45 years after onset: Seizure outcome and predictors
2013 · External reference
Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME)
10.1016/j.seizure.2014.08.004 · 2014 · External reference
Adjunctive behavioural treatment in adolescents and young adults with juvenile myoclonic epilepsy
10.1053/seiz.2000.0479 · 2001 · External reference
Characteristics of valproic acid resistant juvenile myoclonic epilepsy
10.1053/seiz.2000.0432 · 2000 · External reference
Clinical factors of drug resistance in juvenile myoclonic epilepsy
10.1136/jnnp.70.2.240 · 2001 · External reference
CLINICAL, NEUROPSYCHOLOGICAL AND NEUROPHYSIOLOGICAL CORRELATES OF DRUG RESISTANT JUVENILE MYOCLONIC EPILEPSY
10.18410/jebmh/2015/780 · 2015 · External reference
Determination of the factors that cause valproic acid resistance in the pediatric juvenile myoclonic epilepsy cohort
10.5455/medscience.2021.08.244 · 2022 · External reference
Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy
10.1016/j.seizure.2014.03.017 · 2014 · External reference
High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high
10.1016/j.yebeh.2016.04.047 · 2016 · External reference
Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center
10.1016/j.yebeh.2018.03.002 · 2018 · External reference
Long-Term Seizures Outcome in Juvenile Myoclonic Epilepsy (JME): A Retrospective Cohort Study in an Indian Population
10.1055/s-0041-1729459 · 2021 · External reference
Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy
10.1016/j.seizure.2019.06.021 · 2019 · External reference
Short-term results of vagus nerve stimulation in pediatric patients with refractory epilepsy
10.1016/j.pedneo.2012.04.005 · 2012 · External reference
Unresolved reference
External reference
Genetic susceptibility in Juvenile Myoclonic Epilepsy: Systematic review of genetic association studies
10.1371/journal.pone.0179629 · 2017 · External reference
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
10.1136/bmj.d5928 · 2011 · External reference
Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
2014 · External reference
Conducting meta-analyses in R with the metafor package
10.18637/jss.v036.i03 · 2010 · External reference
Measuring inconsistency in meta-analyses
10.1136/bmj.327.7414.557 · 2003 · External reference
When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy
10.1136/jnnp.2010.217976 · 2010 · External reference
Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients
10.1016/s1059-1311(98)90005-x · 1998 · External reference
Health literacy and education level correlates of participation and outcome in a remotely delivered epilepsy self-management program
10.1016/j.yebeh.2020.107026 · 2020 · External reference
Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed
10.1136/pmj.79.928.78 · 2003 · External reference
Seizure outcome in 175 patients with juvenile myoclonic epilepsy A long-term observational study
10.1016/j.eplepsyres.2014.09.008 · 2014 · External reference
Alcohol Use and Alcohol-Related Seizures in Patients With Epilepsy
10.3389/fneur.2018.00401 · 2018 · External reference
Alcohol and drugs in epilepsy: Pathophysiology, presentation, possibilities, and prevention: Alcohol, Drugs, and Seizures
10.1111/j.1528-1167.2012.03613.x · 2012 · External reference
Seizures in Alcohol-Dependent Patients: Epidemiology, Pathophysiology and Management
10.2165/00023210-200317140-00002 · 2003 · External reference
ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions
10.1111/epi.17236 · 2022 · External reference
Juvenile myoclonic epilepsy: An autosomal recessive disease
10.1002/ana.410250504 · 1989 · External reference
The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant
10.1016/j.yebeh.2005.07.014 · 2005 · External reference
Polyamines: The possible missing link between mental disorders and epilepsy (Review)
2019 · External reference
Adherence to treatment in patients with juvenile myoclonic epilepsy: correlation with quality of life and adverse effects of medication
10.1590/s1676-26492009000400010 · 2009 · External reference
What happens to children with epilepsy when they become adults? Some facts and opinions
10.1016/j.pediatrneurol.2014.02.020 · 2014 · External reference
Le point sur le droit de prescription en kinasitherapie
10.1016/s1779-0123(08)70679-x · 2008 · External reference
Predictors of Outcome in Juvenile Myoclonic Epilepsy
10.2147/rmhp.s244725 · 2020 · External reference
Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study
10.1093/brain/awg262 · 2003 · External reference
Mechanisms underlying status epilepticus
10.1358/dot.2005.41.4.908564 · 2005 · External reference
Early Predictors of Drug-Resistant Epilepsy Development after Convulsive Status Epilepticus
10.1159/000490900 · 2018 · External reference
Status epilepticus in patients with juvenile myoclonic epilepsy: Frequency, precipitating factors and outcome
10.1016/j.yebeh.2016.07.038 · 2016 · External reference
Epileptiform Asymetries and Treatment Response in Juvenile Myoclonic Epilepsy
10.1017/s0317167100051519 · 2010 · External reference
Auras in generalized epilepsy
10.1212/wnl.0000000000000877 · 2014 · External reference
Genetics of epilepsy syndromes in families with photosensitivity
10.1212/wnl.0b013e31828ab349 · 2013 · External reference
Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis
10.1016/j.eclinm.2022.101732 · 2022 · External reference
